The World Health Organization cancer agency, the International Agency for Research on Cancer, has released the latest estimates of the global burden of cancer.
FDA issued a draft guidance for industry that, when finalized, will provide sponsors with recommendations for conducting multiregional clinical trials in support of applications for drugs intended to treat cancer.
